Atıf İçin Kopyala
USLU A., TÖZ H. , ŞEN S. , ALKAN F. T. , NART A., AYKAS A., ...Daha Fazla
TRANSPLANTATION PROCEEDINGS, cilt.41, ss.756-763, 2009 (SCI İndekslerine Giren Dergi)
Background. There is an emerging consensus on conversion from calcineurin inhibitor (CNI)-based regimens to proliferation signal inhibitor (PSI)-based protocols for the prevention of a progressive decline in graft function due to CNI toxicity.